Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00065156
Status:
COMPLETED
Last Update Posted:
2019-11-19
First Post:
2003-07-17
Brief Title:
Lenalidomide SafetyEfficacy in Myelodysplastic Syndromes MDS Associated With a Deletion Del5q Cytogenetic Abnormality
Sponsor:
Celgene
Organization:
Celgene
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2008-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08-01
Completion Date Type:
ACTUAL
First Submit Date:
2003-07-17
First Submit QC Date:
July 17 2003
Study First Post Date:
2003-07-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-06-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-06
Last Update Post Date:
2019-11-19
Last Update Post Date Type:
ACTUAL